Publishing Details
Contact & Outreach
About This Podcast
Hosted on Acast. See acast.com/privacy for more information.
Explore Statistics
Recent Episodes
S10E8 PrEP: The Newest Chapter
In this issue: The long-awaited approval of a second long-acting injectable PrEP formulation — twice-yearly lenacapavir — has come. What are the most important things clinicians need to understand…
S10E6 Youth & HIV: Understanding the Unique Challenges
In this issue we focus on youth: the 13 to 24-year-old population responsible for nearly 20% of new HIV diagnoses in the US. Their entry into the HIV care continuum has been slow, hindered by…
S10E4 Managing HIV-Related Comorbidities in an Aging Population
PWH. People living with HIV. They’re growing older. And they’re experiencing the same illnesses of aging — CVD, kidney and liver diseases, cancers — as their HIV-seronegative counterparts. The…
S9E2 Overcoming Barriers to PrEP in Rural America
PrEP. For most patients, that’s a simple drug regimen that can be prescribed after a negative HIV screen. Safe. Effective. Proactive protection to stop the spread of HIV infection in MSM, cisgender,…
S9E12 New Directions in Long-Acting ART and Long-Acting PrEP
How will the current research advancements in long-acting ART affect clinicians’ ability to provide better care for their patients with HIV? The recent data show that the low uptake and adherence to…
S9E10 PLWH & SUD: A Clinical Perspective
The primary health concern for all individuals living with HIV should be managing their disease, particularly maintaining adherence to their ART treatment. Yet for many, the more immediate demands of…
S9E8 PLWH: Overcoming Post-Incarceration Care Disengagement
People living with HIV who’ve had criminal legal involvement face significant challenges that complicate their ability to remain in the HIV care continuum. Many, while incarcerated, have stopped…
S9E6 Managing HIV in an Aging Population
Widespread use of highly effective ART has increased the life expectancy of people living with HIV (PLWH) to close to that of the general population. But despite highly effective viral suppression,…
S9E4 Managing HIV Coinfections: HBV and TB
Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the…
S9E2 ART, HRT, Pregnancy, and Menopause in Women Living With HIV
Pregnancy and menopause — for many women, these are two of the most significant healthcare events in their lives. For WLWH (women living with HIV) and their healthcare providers, managing these…
Clinical Approaches to Marginalized Populations
In part 1 of this eHIV Review Special Edition (still available at eHIVreview.org), eHIV Review Program Director Justin Alves, Nurse Educator at Boston Medical Center, reviewed the recent evidence…
Addressing the Needs of Marginalized Populations - Mehtani
Marginalized individuals at risk for or living with HIV — the formerly incarcerated, immigrants, people with unstable housing, residents of rural communities, the rising number with substance use…
Addressing the Needs of Marginalized Populations - Loukas
Marginalized individuals at risk for or living with HIV — the formerly incarcerated, immigrants, people with unstable housing, residents of rural communities, the rising number with substance use…
S8E12 HIV Stigma: A Psychologist’s Viewpoint
A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What…
S8E10 AYA and Ending the HIV Epidemic
A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What…
S8E8 Delivering High-Quality HIV Care to Cisgender and Transgender Women
Why do cisgender and transgender women, and particularly women of color, account for such a disproportionate percentage of HIV infections in the US? Why are so many so reluctant to accept PrEP? What…
S8E6 Newer NNRTI Agents in Clinical Practice
Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors…
S8E4 Emerging HIV Therapies and Potential Clinical Uses
Hosted on Acast. See acast.com/privacy for more information.
S8E2 Stigma and HIV Care in LGBTQ+ Persons
Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their…
S7E12 Newer Options for Treatment-Experienced Patients Podcast
Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized…
Frequently Asked Questions
eHIV Review has published 65 episodes since July 2012, covering topics in Health & Fitness, Medicine.
eHIV Review is currently highly active with new episodes every 2 months. Average episode length is 24m.
Sign up on Grep.FM to access contact details for eHIV Review, including email and social media links.
Similar Podcasts
Sawbones: A Marital Tour of Misguided Medicine
Justin McElroy, Dr. Sydnee McElroy
584 episodes
The Dr. Hyman Show
Dr. Mark Hyman
1,147 episodes
The Peter Attia Drive
Peter Attia, MD
442 episodes
The Exam Room by the Physicians Committee
Physicians Committee
767 episodes
Dhru Purohit Show
Dhru Purohit
493 episodes
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
500 episodes